BMC Cancer (Nov 2022)
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
- C. Martínez-Laperche,
- L. Sanz-Villanueva,
- F. J. Díaz Crespo,
- P. Muñiz,
- R. Martín Rojas,
- D. Carbonell,
- M. Chicano,
- J. Suárez-González,
- J. Menárguez,
- M. Kwon,
- J. L. Diez Martín,
- I. Buño,
- M. Bastos Oreiro
Affiliations
- C. Martínez-Laperche
- Gregorio Maranon Health Research Institute (IiSGM)
- L. Sanz-Villanueva
- Gregorio Maranon Health Research Institute (IiSGM)
- F. J. Díaz Crespo
- Gregorio Maranon Health Research Institute (IiSGM)
- P. Muñiz
- Gregorio Maranon Health Research Institute (IiSGM)
- R. Martín Rojas
- Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM)
- D. Carbonell
- Gregorio Maranon Health Research Institute (IiSGM)
- M. Chicano
- Gregorio Maranon Health Research Institute (IiSGM)
- J. Suárez-González
- Gregorio Maranon Health Research Institute (IiSGM)
- J. Menárguez
- Gregorio Maranon Health Research Institute (IiSGM)
- M. Kwon
- Gregorio Maranon Health Research Institute (IiSGM)
- J. L. Diez Martín
- Gregorio Maranon Health Research Institute (IiSGM)
- I. Buño
- Gregorio Maranon Health Research Institute (IiSGM)
- M. Bastos Oreiro
- Gregorio Maranon Health Research Institute (IiSGM)
- DOI
- https://doi.org/10.1186/s12885-022-10335-7
- Journal volume & issue
-
Vol. 22,
no. 1
pp. 1 – 2
Abstract
No abstracts available.